Compare WMK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMK | PLSE |
|---|---|---|
| Founded | 1912 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 1994 | 2015 |
| Metric | WMK | PLSE |
|---|---|---|
| Price | $78.22 | $25.33 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 113.9K | ★ 366.1K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.13 | N/A |
| Revenue | ★ $4,714,573,000.00 | N/A |
| Revenue This Year | N/A | $840.00 |
| Revenue Next Year | N/A | $287.54 |
| P/E Ratio | $66.97 | ★ N/A |
| Revenue Growth | ★ 0.01 | N/A |
| 52 Week Low | $59.99 | $12.56 |
| 52 Week High | $79.05 | $28.53 |
| Indicator | WMK | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 71.58 | 53.84 |
| Support Level | $67.74 | $17.58 |
| Resistance Level | N/A | $26.30 |
| Average True Range (ATR) | 2.32 | 1.62 |
| MACD | 0.44 | -0.05 |
| Stochastic Oscillator | 90.98 | 28.60 |
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.